Biomarker Quantification, Deep Learning

Transfer Learning Between Multiple Therapeutic Areas

Many pharmaceutical companies develop their AI capabilities to improve operational efficiencies, scientific research, and the clinical trial process. As for medical image analysis, the complexity and heavy investment of time and effort lead them to turn to specialized partners who possess this expertise. Keen Eye holds a prominent position in this field with significant knowledge in […]

By Eunice, 3 months ago
Biomarker Discovery, Deep Learning

Artificial Intelligence and the fight against cancer: how deep learning aids in lung cancer subtyping

At the forefront of AI research in medicine are diagnostics and drug development. Deep learning technology allows better decision making, improved efficiency in clinical trials, and a clearer path to drug development. Keen Eye applies deep learning technology to imitate and enhance the visual expertise of a medical expert. Compared to the traditional image analysis […]

By Eunice, 5 months ago

Keen Eye Selected as a French Finalist in AWS Global Startup Challenge

February 2020, PARIS – Keen Eye was selected as a finalist for the France region in the Startup Architecture of the Year Challenge for 2020. This global competition organized by Amazon Web Services (AWS) gave startups building their infrastructure on the AWS platform the opportunity to showcase their work. Firms in various industries such as […]

By Fanny, 6 months ago

Keen Eye: Fighting Cervical Cancer A Deep Learning Solution to Help the Screening of the Disease

April 6, 2019, PARIS  – KEEN EYE laureate of the 7th edition of the Concours d’Innovation Numérique – CIN – « Live Better » category   The solution developed by Keen Eye, a French startup specialized in digital technology, has caught the attention of the jury* of the French 7th edition of the Concours d’Innovation […]

By Fanny, 1 year ago